Navigation Links
Malignant Mesothelioma – A New Genetic Revelation,

cancer. And, some people who have never smoked get lung cancer. Normal lung tissue is made up of cells that are programmed by nature to create lungs of a certain shape and function.

http://www.medindia.net/patients/
patientinfo/lungcancer_about.htm

Further Information from Medindia on Mesethelioma

In men who die of lung cancer (squamous and undifferentiated), all of whom were smokers, the remainder of the epithelial lining shows changes that may be considered as preliminary stages to the development of lung cancer, including early invasion. There are few such changes in nonsmokers, but they increase rapidly with the amount of cigarette smoking.

By-Oscar Auerbach, Arthur Purdy Stout, Edward Cuyler Hammond, Lawrence Garfinkel, 1964

Malignant mesothelioma is a disease in which the cancer cells are found in the pleural area (Pleura is the thin layer of tissue that is between the chest cavity and the lungs) or the peritoneum (peritoneum is a thin layer of tissue that lines most of the organs in the abdomen). Mesothelioma has so far been an incurable cancer and once diagnosed most patients will die within a year.

www.medindia.com/patients/
patientinfo/
mesothelioma_cancer_intro.htm

'"/>




Page: 1 2 3

Related medicine news :

1. Malignant Mesothelioma – A New Genetic Revelatio
2. Malignant virus in polio vaccine combined to Cancer
3. Experimental Therapy Effective Against Malignant Melanoma in Horses
4. Protein Involved In Embryo Formation Found In Malignant Cells
5. Novel Suicide Gene Therapy Used to Treat Malignant Brain Tumors
6. Detection of Malignant Breast Tumors Made Simpler and More Effective
7. Malignant Mesothelioma – A New Genetic Revelatio
8. ‘Mesothelioma’- Trouble Under the Asbestos Rof
9. Genetic Dentistry: Your Dentist may be able to grow you a new set of Teeth.
10. Genetic influence in menopause
11. Genetics and cholesterol levels
Post Your Comments:
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5Video 3A Plan for Long Term Care Before the Crisis Hits 47797 1Video 3A Plan for Long Term Care Before the Crisis Hits 47797 2Video 3A Plan for Long Term Care Before the Crisis Hits 47797 3Video 3A Plan for Long Term Care Before the Crisis Hits 47797 4Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 1Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 2Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 3Stepping up minority recruiting 47791 1Stepping up minority recruiting 47791 2Stepping up minority recruiting 47791 3